Modafinil
Centrally Acting Sympathomimetics
Sold as Provigil · ALERTEC
- Drug class
- Centrally Acting Sympathomimetics
- Availability
- Prescription only
- Routes
- Oral
- Markets covered
- 3
- Products on record
- 26
- FDA reports (12 mo)
- 758
Overview
Modafinil is an active pharmaceutical ingredient in the Centrally Acting Sympathomimetics group (N06BA). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 14 | April 24, 2026 |
| CA Canada | Health Canada | 9 | April 27, 2026 |
| US United States | FDA | 3 | August 27, 2025 |
GBUnited Kingdom· MHRA
14 products
Uses
Provigil is indicated in adults for the treatment of excessive sleepiness associated with narcolepsy with or without cataplexy. Excessive sleepiness is defined as difficulty maintaining wakefulness and an increased likelihood of falling asleep in inappropriate situations.
How to take
CACanada· Health Canada
9 products
Uses
ALERTEC (modafinil) is indicated for: • The symptomatic treatment of excessive sleepiness in adult patients with narcolepsy. In narcolepsy, ALERTEC has no significant effect on cataplexy. • The symptomatic treatment of excessive sleepiness in adult patients with obstructive sleep apnea (OSA).
In OSA, ALERTEC is indicated as an adjunct to successful standard treatment(s) for the underlying obstruction, when excessive sleepiness persists. If continuous positive airway pressure (CPAP) is the treatment of choice for a patient with OSA, a maximal effort to treat with CPAP for an adequate period of time should be made prior to initiating ALERTEC.
If ALERTEC is used adjunctively with CPAP, the encouragement of and periodic assessment of CPAP compliance is necessary. • The symptomatic treatment of excessive sleepiness in adult patients with circadian rhythm sleep disorder, shift work type (shift work disorder) (SWD).
In SWD, ALERTEC (modafinil) is indicated for the symptomatic treatment of excessive sleepiness (as confirmed by multiple sleep latency test) associated with loss of a normal sleep-wake pattern (as confirmed by polysomnography). Daytime sleep (as measured by polysomnography) in SWD is not affected by the use of ALERTEC.
USUnited States· FDA
3 products
Uses
1 INDICATIONS AND USAGE Modafinil tablets are indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea (OSA), or shift work disorder (SWD). Limitations of Use In OSA, modafinil tablets are indicated to treat excessive sleepiness and not as treatment for the underlying obstruction.
If continuous positive airway pressure (CPAP) is the treatment of choice for a patient, a maximal effort to treat with CPAP for an adequate period of time should be made prior to initiating and during treatment with modafinil tablets for excessive sleepiness.
Modafinil tablets are indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea (OSA), or shift work disorder (SWD). ( 1 ) Limitations of Use In OSA, modafinil tablets are indicated to treat excessive sleepiness and not as treatment for the underlying obstruction.
Drug interactions
Known interactions involving Modafinil. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 587. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL147760098 · revised January 30, 2026
- [2]Health Canada (DPD) · 02239665 · revised April 27, 2026
- [3]FDA DailyMed · 013450dd-cd42-46… · revised January 15, 2025 [PDF]
- [4]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.